Results suggested that the miR-363 might reduce tumorigenicity and tumor progression in a nude mouse model, which further confirmed that miR-363 might suppress cell proliferation, migration and invasion by targeting E2F3 in CRC. This evidence concerns the gene E2F3 and colorectal carcinoma.